GSK547
GSK547 (GSK'547) is a highly selective and potent inhibitor of receptor-interacting serine/threonine protein kinase 1 (RIPK1), inhibits macrophage-mediated adaptive immune tolerance in pancreatic cancer[1].
Product Specifications
CAS Number
[2226735-55-1]
Product Name Alternative
GSK'547
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk547.html
Concentration
10mM
Purity
99.92
Solubility
DMSO : 175 mg/mL (ultrasonic)
Smiles
N#CC1=NC=NC(N2CCC(C(N3N=CC[C@H]3C4=CC(F)=CC(F)=C4)=O)CC2)=C1
Molecular Formula
C20H18F2N6O
Molecular Weight
396.39
Precautions
H315, H319, H320
References & Citations
[1]Wang W, et al. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Cancer Cell. 2018 Nov 12;34 (5) :757-774.e7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
